Clinical Trial Update: Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates diindolylmethane in men with nonmetastatic prostate cancer that has not responded to prior hormone therapy. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Diindolylmethane (diindolylmethane)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED